How Coronary Artery Disease Progresses and Why Treatment Starts With Risk Assessment

The letter arrived on a Tuesday. A routine health check, a few numbers in a table, and one line that stuck: his estimated ten-year risk of a heart attack or stroke sat above the threshold where his doctor wanted to talk. He felt fine. He walked the dog every morning. He had never once thought about the inside of his arteries.

That evening he searched for how atherosclerosis is treated and found a confusing mix: stents, bypass operations, statins, diets promising to scrub arteries clean. None of it explained why a man with no symptoms was being asked to act, or why his neighbor with the same cholesterol had been told simply to come back in five years.

The answer lies in a principle that runs through every major heart guideline. Treatment is not chosen by the presence of plaque alone. It is chosen by how likely that plaque is to cause harm, and that begins with an honest, numbers-based risk assessment.

How does coronary artery disease progress over time?

Atherosclerosis is the slow build-up of fatty, fibrous and calcified deposits, called plaque, inside the walls of arteries. When it happens in the vessels that feed the heart muscle, it is called coronary artery disease. The word that matters most in that description is slow. The earliest fatty streaks appear in the artery walls of young adults, sometimes teenagers, and typically take decades to grow into anything that restricts blood flow.

Progression is not a straight line. A plaque can sit quietly for years, then enlarge during a stretch of poorly controlled blood pressure or after a smoking relapse, then settle again. As the deposit thickens, the artery’s open channel narrows. Once narrowing is severe enough, the heart muscle may not receive enough oxygen when demand rises, which produces the pressure-like chest discomfort on exertion known as stable angina.

The more dangerous turn is different. Many heart attacks begin not when an artery finally closes from gradual narrowing, but when the thin cap covering a soft, inflamed plaque cracks. Blood meets the fatty core, a clot forms within minutes, and flow stops abruptly. Plaques that rupture this way are often not the most narrowed ones on a scan. This is why a person can pass a stress test and still have a heart attack months later, and why treatment is aimed at making plaques calmer and less likely to break, not only at opening the tightest spots.

Three forces drive the process at every stage: the amount of cholesterol-carrying particles in the blood, the pressure and chemical injury the artery lining absorbs, and the level of inflammation within the wall. Each of those forces is measurable, and each is a target. Understanding coronary artery disease progression as a lifelong, adjustable process rather than a sudden event is the foundation for everything that follows.

How atherosclerosis is treated: why it starts with risk assessment

Ask a cardiologist how atherosclerosis is treated and the first answer will usually be a question in return: treated in whom? Someone who has already had a heart attack is treated very differently from a healthy forty-year-old with mildly raised cholesterol, even though both technically have plaque in their arteries.

The reason is that most treatments carry a cost in effort, side effects or procedural risk, and the benefit of any treatment scales with how likely the bad outcome was in the first place. Lowering cholesterol by a given amount prevents far more events in a group of people at high risk than in a group at low risk, simply because the high-risk group had more events coming. Guideline bodies in the United States, the United Kingdom and Europe all build their recommendations around this arithmetic.

A useful way to picture it is flood defense. A town does not build the same wall along every stretch of river. Engineers estimate where water is most likely to breach, then match the height and expense of the barrier to that estimate. Cardiovascular risk assessment does the same job for arteries. It estimates the probability of a heart attack or stroke over roughly the next ten years and sorts people into tiers.

Every tier receives the foundation: not smoking, regular movement, a heart-protective eating pattern and control of weight and blood pressure. Higher tiers add medicines that lower cholesterol, reduce clotting tendency and protect the artery lining. Procedures such as stenting or bypass surgery sit at the top and are used for symptoms that medicines cannot control, or for acute blockages, rather than as a general treatment for plaque.

That structure explains the neighbor with the same cholesterol reading but a different plan. Cholesterol is one number among several. Risk is the sum, and treatment intensity follows the sum.

What actually happens inside an artery wall

Picture the inside of a healthy artery as a smooth, single-cell lining called the endothelium, a living barrier that regulates what passes into the wall beneath it. Atherosclerosis begins when that barrier is irritated. High blood pressure batters it mechanically. Chemicals in tobacco smoke poison it. Persistently high blood sugar stiffens and inflames it. Wherever the lining is damaged, low-density lipoprotein particles, the cholesterol carriers usually shortened to LDL, slip through and lodge in the wall.

Once inside, LDL is chemically altered by oxidation, and the immune system reads it as a threat. White blood cells called macrophages arrive, swallow the altered cholesterol and swell into what pathologists call foam cells because of their bubbly appearance under a microscope. As foam cells die, they leave behind a soft pool of fat and debris: the plaque’s core.

The body tries to wall this off. Muscle cells from deeper in the artery migrate over the core and lay down fibrous tissue, forming a cap. Over years, calcium salts deposit within the plaque, which is why older plaques show up on CT scans and why a coronary calcium score can be counted at all.

Whether a plaque is dangerous depends largely on the cap. A thick, fibrous, calcified cap over a small core is stable; it may narrow the artery but rarely ruptures. A thin cap over a large, inflamed fatty core is vulnerable. Continued inflammation thins the cap further, and a surge in blood pressure or a spasm can tear it.

This mechanism is the reason treatment looks the way it does. Reducing LDL shrinks the raw material entering the wall and allows the core to become less fatty and more fibrous. Controlling blood pressure lowers the mechanical stress on the cap. Stopping smoking removes a direct chemical injury. Antiplatelet medicines make blood less able to clot if a crack does occur. Each intervention interrupts one step in a chain that has been understood for decades.

How doctors estimate your risk and what the tests actually measure

Risk assessment starts with a conversation and a set of measurements that most people can obtain in a single visit. Blood pressure is recorded, ideally on more than one occasion. A blood sample provides a lipid profile: total cholesterol, LDL, high-density lipoprotein (HDL, the fraction that carries cholesterol away from tissues) and triglycerides, another fat that travels in the blood. Blood sugar or a longer-term glucose marker screens for diabetes. Kidney function is often checked because kidney disease accelerates artery damage.

These values are entered into a validated calculator along with age, sex, smoking status and diabetes. In the United States the most widely used tool is the pooled cohort equation promoted by the American Heart Association and the American College of Cardiology; in England, general practitioners use the QRISK tool, and the NHS offers a health check to adults between 40 and 74 that includes this calculation. The output is a percentage: the estimated probability of a heart attack or stroke over the next ten years.

Calculators are only a starting point. Clinicians then weigh factors the equations handle poorly: a parent or sibling who had a heart attack early, certain ethnic backgrounds, inflammatory conditions such as rheumatoid arthritis or psoriasis, a history of pregnancy complications like pre-eclampsia, and chronic kidney disease. Any of these can nudge a borderline estimate upward.

When the picture remains uncertain, a coronary artery calcium scan may be used. This is a quick CT of the heart that counts calcified plaque and expresses it as a score. A score of zero in someone with a middling risk estimate is reassuring; a high score often tips a decision toward medicine. People who already have symptoms move onto a different pathway that may include an exercise stress test, an echocardiogram (an ultrasound of the heart) or angiography, in which dye outlines the coronary arteries directly.

Every one of these tests describes probability at the population level. It cannot say whether you, specifically, will have an event. That limitation is exactly why the results are discussed rather than simply announced.

What your risk score changes about how atherosclerosis is treated

The risk estimate sorts people into broad groups, and each group carries a characteristic plan. Guidelines vary slightly in where they draw the lines, but the shape is consistent across major bodies.

Low estimated risk with no known disease is the largest group. Here the plan is lifestyle and time. The person is encouraged to stay active, avoid tobacco, eat well and return for repeat measurement at an interval the clinician sets. Medicines are usually not advised because the absolute benefit would be small and the modest side-effect burden would apply to everyone taking them.

Intermediate risk is the zone of genuine shared decision-making. A statin, a class of medicine that lowers LDL by reducing the liver’s cholesterol production, may be reasonable but is not automatic. This is where risk-enhancing factors and calcium scoring earn their place, and where personal values matter: some people would rather take a daily tablet than accept a one-in-ten chance of an event, others feel the opposite. Both are legitimate.

High risk without established disease, for example in people with diabetes plus other risk factors or a very high LDL, generally shifts the recommendation firmly toward medicine alongside lifestyle. Established disease, meaning a previous heart attack, stroke, stent, bypass or symptomatic narrowing anywhere in the body, is treated as the highest tier regardless of what a calculator says. Here the aim is secondary prevention, and the medicine list typically lengthens to include an antiplatelet and more ambitious cholesterol goals set by the prescriber.

Younger adults deserve a note. Ten-year calculators are heavily weighted by age, so a person in their thirties with a strongly adverse profile may score as low risk simply because ten years is a short window. Clinicians increasingly consider lifetime risk in this group, and family history of early heart disease can prompt earlier testing for inherited cholesterol disorders.

Lifestyle changes with the strongest evidence behind them

Lifestyle sits in the first line of every guideline not because it is gentle but because it works on several parts of the mechanism at once. It also applies to every tier, from the person told to come back in five years to the person leaving hospital after bypass surgery.

Stopping smoking is the single most powerful change available to a smoker. Tobacco smoke injures the artery lining directly, makes platelets stickier and lowers HDL. The benefit begins as soon as the exposure stops and continues to grow, and supported quitting, combining behavioral help with clinician-guided aids, is more effective than willpower alone.

Movement is the second pillar. The American Heart Association recommends at least 150 minutes a week of moderate-intensity aerobic activity, such as brisk walking, or 75 minutes of vigorous activity, plus muscle-strengthening work on two days. Spread across a week, that is five brisk half-hour walks. Activity lowers blood pressure, improves how the body handles sugar and modestly raises HDL.

Eating patterns matter more than individual foods. The approaches with consistent evidence share features: plentiful vegetables, fruit, legumes, whole grains, nuts and fish; olive or other unsaturated oils in place of butter and hard fats; limited red and processed meat; little added sugar and less salt. A Mediterranean-style pattern is the most studied example. No single ingredient is magic, and no single one is forbidden.

Weight, alcohol and sleep round out the picture. Even modest weight reduction improves blood pressure and glucose. Alcohol offers no proven protection to arteries and raises blood pressure at higher intakes. Poor sleep and untreated sleep apnea, a condition in which breathing repeatedly pauses overnight, both push blood pressure up.

The honest caveat is that lifestyle alone may not bring cholesterol or blood pressure to the ranges a high-risk person needs. That is not failure; it is the point at which medicines are added, not substituted.

Which medicines are used for atherosclerosis and how they work

Medicines for atherosclerosis are chosen by mechanism, and each class addresses one of the forces described earlier. What follows describes what these classes do; whether any of them is right for a given person, and in what form, is a decision for the prescribing clinician.

Cholesterol-lowering medicines target the raw material of plaque. Statins reduce an enzyme the liver uses to make cholesterol, which prompts liver cells to pull more LDL out of the bloodstream. Ezetimibe limits absorption of cholesterol from the gut and is often used alongside a statin. Newer injectable antibodies known as PCSK9 inhibitors keep the liver’s LDL receptors working longer and are generally reserved for people with very high LDL or established disease. Blood tests taken after an interval the prescriber sets show how far LDL has fallen.

Blood-pressure medicines reduce mechanical stress on the artery wall. Several classes exist, including ACE inhibitors and angiotensin receptor blockers, which relax vessels through a hormone pathway; calcium channel blockers, which relax vessel muscle directly; and beta blockers, which slow the heart and are often used after a heart attack or for angina.

Antiplatelet medicines, such as aspirin or other agents, make platelets less able to clump, so a plaque that cracks is less likely to trigger an artery-blocking clot. Because they also raise bleeding risk, they are generally reserved for people with established disease rather than used for prevention in everyone.

For people with diabetes, certain newer glucose-lowering classes have shown cardiovascular benefit in trials beyond their effect on sugar, and guidelines now consider heart risk when choosing among them. Anti-inflammatory approaches are an active research area; some agents have reduced events in trials, but their place in routine care is still being defined.

Muscle aches, digestive upset and dizziness are among the effects people commonly report. These are worth raising with the prescriber rather than managing alone, since alternatives within each class usually exist.

When stents or bypass surgery enter the picture

Procedures are the part of treatment most people picture first, yet they are used in a minority of those with atherosclerosis and for specific reasons.

Coronary angioplasty is a procedure in which a thin tube is threaded from an artery in the wrist or groin to the heart, a small balloon is inflated at the narrowed point, and in most cases a stent, a tiny mesh scaffold, is left in place to hold the artery open. It is done under local anesthetic with sedation, and the person is usually awake. Coronary artery bypass grafting, known as CABG, is open surgery in which a vein or artery taken from elsewhere in the body is stitched in to carry blood around a blockage. Modern versions of both are refined, but neither removes plaque from the arterial tree; they restore flow at one location.

During a heart attack, opening the blocked artery quickly with a stent limits muscle damage, and this is the clearest indication. In stable disease, the picture is more nuanced. Large randomized trials in people with stable angina found that adding a stent to good medical treatment relieved symptoms for many but did not reduce future heart attacks or deaths compared with medicines alone. Guidelines therefore treat stenting in stable disease mainly as a treatment for symptoms that persist despite medicines.

Bypass surgery is usually considered when disease involves several vessels or the main trunk of the left coronary artery, particularly in people with diabetes, where trials have favored surgery for longer-term outcomes. The choice between stent and surgery is typically made by a team including cardiologists and cardiac surgeons.

Both carry risks that are discussed in consent conversations: bleeding or damage at the access site, clotting within a stent, kidney strain from contrast dye, and, for surgery, infection, irregular heart rhythm and stroke. Medicines and lifestyle continue after either procedure, because the disease elsewhere in the arteries has not changed.

Who is usually treated intensively, and who is usually asked to wait

Because treatment scales with risk, it helps to know which situations typically prompt an intensive plan and which typically prompt watchful waiting. These are patterns from guidelines, not rules that override an individual assessment.

Intensive treatment is the norm for anyone with established disease: a prior heart attack or stroke, a stent or bypass in the past, or narrowing that has caused symptoms in the heart, brain, or legs. It is also usual for people with diabetes who carry additional risk factors, those with chronic kidney disease, and anyone with a very high LDL level, especially when it points toward familial hypercholesterolemia, an inherited condition in which the liver clears LDL poorly from birth. In these groups the medicine list is longer and the cholesterol targets set by clinicians are more ambitious.

Watchful waiting is common for younger adults with a low calculated risk, for people whose estimate sits in the borderline zone and whose calcium score is zero, and for those in whom a small amount of plaque was found incidentally on a scan done for another reason and who have no symptoms. Waiting in this sense is not doing nothing. It means committing to the lifestyle foundation and returning for repeat measurements on a schedule the clinician sets, so that a change in trajectory is caught early.

Procedures are deferred for people whose stable angina is controlled by medicines, since the evidence does not show that stenting adds protection in that situation. They are also weighed carefully in people with frailty, advanced kidney disease or other serious illness, where the risks of the intervention may outweigh what it could offer.

Older adults are a group where the calculators become less reliable and personal goals matter more. Someone in their eighties may reasonably choose fewer medicines and accept a higher risk, or may want everything available. Both paths are supported when the conversation has been honest, and the treating team’s role is to lay out the trade-offs clearly.

Atherosclerosis treatment options compared

The table below sets the main approaches side by side. Its most useful column is the last one, because misunderstanding what a treatment does not do causes more disappointment than any side effect.

Approach	What it does	Who usually receives it	What it does not do
Lifestyle changes	Lower blood pressure, improve glucose and lipid handling, reduce inflammation, remove tobacco injury	Everyone, at every risk level	May not reach the cholesterol or pressure ranges needed at high risk on its own
Cholesterol-lowering medicines	Reduce LDL entering the artery wall; allow plaque cores to become less fatty and more stable	Intermediate to high risk; everyone with established disease unless not tolerated	Do not dissolve calcified plaque or open a severely narrowed artery
Blood-pressure medicines	Reduce mechanical stress on the artery lining and plaque caps	Anyone with persistently raised pressure; most people after a heart attack	Do not lower cholesterol or remove existing plaque
Antiplatelet medicines	Make platelets less likely to form a clot if a plaque cracks	People with established disease	Do not prevent plaque growth; add bleeding risk
Angioplasty and stent	Open one narrowed segment and hold it open	Heart attack; stable angina not controlled by medicines	Does not treat plaque elsewhere; in stable disease does not reduce heart attacks beyond medicines
Bypass surgery	Routes blood around one or more blockages using a graft	Multi-vessel or left main disease, often with diabetes	Does not stop the underlying disease; grafts can themselves develop plaque

Two patterns stand out. First, the rows are cumulative rather than alternatives. A person who has a stent still needs the lifestyle row and usually the three medicine rows. Second, only the first three rows act on the disease process itself; the last three manage its consequences. Treatment plans that emphasize the top of the table are not a lesser option. They are the part that changes the future of every artery, not just one.

What the following weeks usually look like after treatment begins

The weeks after a treatment decision feel different depending on which path was taken, but each has a recognizable rhythm.

After starting medicines, the first stretch is about tolerance and confirmation. People are asked to notice and report new muscle aches, stomach upset, dizziness on standing or unusual bruising. A follow-up blood test, scheduled by the prescriber, checks how far cholesterol has moved and whether liver or kidney markers have shifted. If the response is short of the target, the clinician may adjust the plan; that adjustment is theirs to make, and stopping a medicine because one feels well is a decision to raise with them rather than take alone.

After a stent, most people leave hospital quickly and are given specific instructions about the access site in the wrist or groin, about avoiding heavy lifting for a period the team specifies, and about taking antiplatelet medicines exactly as prescribed, since the weeks after stenting are when a clot inside the new scaffold is most likely. Driving and return to work are cleared individually.

Bypass surgery has the longest recovery. According to the NHS, most people stay in hospital for around a week, and a full recovery typically takes about 12 weeks, during which the breastbone heals and activity is rebuilt gradually. Chest wall soreness, tiredness and low mood in the early weeks are common and expected.

Cardiac rehabilitation ties all three paths together. It is a structured program of supervised exercise, education and support that, according to Mayo Clinic, often lasts about three months, though it can be shorter or longer depending on need. Rehabilitation is offered after heart attacks, stents and surgery, and increasingly to people with stable disease, and participation is associated in observational and trial data with better outcomes. Where it is offered, it is worth treating as part of the treatment rather than an optional extra.

Can you reverse atherosclerosis? What the evidence actually shows

This is the question people most want answered and the one that deserves the most careful reply. The short version is that atherosclerosis can be stabilized and, in some people, modestly regressed, but it cannot be cleared away, and no diet, supplement or program has been shown to make arteries new again.

Here is what the evidence supports. Trials that imaged coronary arteries with ultrasound from inside the vessel before and after intensive LDL lowering found that the volume of soft plaque shrank slightly in many participants and grew less in most others. The change was measured in small percentages of plaque volume, not in arteries returning to normal. What appears to happen is that the fatty core loses lipid and becomes denser and more fibrous, which is the kind of plaque far less likely to rupture. Calcified plaque does not disappear; calcium scores tend to stay the same or rise even in people whose risk is falling, which is why a repeat calcium scan is generally not used to track treatment.

Here is what the evidence does not support. Claims that specific foods, oils, herbal preparations, high-dose vitamins or chelation therapy (an infusion of chemicals that bind metals) dissolve plaque are not backed by controlled trials, and chelation carries real risks. Lifestyle programs can improve cholesterol, blood pressure and symptoms substantially; they have not been shown to remove established disease.

As for how long reversal takes, there is no honest single figure. Imaging studies ran over one to two years and showed gradual change; the benefit that matters, fewer heart attacks and strokes, accumulates over years of sustained treatment rather than arriving at a fixed point. The realistic goal is not an artery with no plaque but a plaque that is stable, an artery lining that is no longer under attack, and a person whose risk trajectory has bent downward. By that standard, the answer to whether atherosclerosis can be turned around is a cautious yes.

What people often get wrong about atherosclerosis

Some misunderstandings about atherosclerosis are harmless. Others lead people to skip the parts of treatment that matter most. These are the ones clinicians hear again and again.

Feeling well means the arteries are fine. Plaque builds silently for decades, and a plaque that ruptures has often caused no symptoms at all. Absence of chest pain says little about risk. The risk assessment exists precisely because symptoms arrive late.

A stent fixes the disease. A stent opens one segment of one artery. The process that created that narrowing continues everywhere else unless cholesterol, blood pressure and smoking are addressed. Many people leave a procedure believing they have been repaired and quietly let their medicines lapse; this is one of the most consequential errors in cardiology.

Normal cholesterol means safe. Cholesterol is one input. Someone with an average LDL but high blood pressure, diabetes and a smoking habit can carry a higher risk than a non-smoker with a higher LDL and nothing else. Risk is the total, which is why the calculators exist.

It is a disease of older men. Women develop coronary disease too, often later and sometimes with different symptoms such as breathlessness or unusual fatigue on exertion, and the process begins in youth for both sexes.

Supplements can clear arteries. Fish oil, garlic, vitamin E and various herbal products have been studied; none has been shown to remove plaque, and some interact with prescribed medicines. Anyone considering a supplement should mention it to the prescriber.

Once the numbers improve, treatment can stop. The improvement is the treatment working, not the disease resolving. Cholesterol and blood pressure return toward their previous levels when the intervention is withdrawn. Any change to a prescribed plan belongs in a conversation with the clinician who prescribed it.

Questions to ask your care team

A good consultation about atherosclerosis is a two-way exchange, and people who arrive with questions tend to leave with clearer plans. The list below is a starting point; not every question fits every situation, and the answers will belong to your own clinician rather than to any article.

• What is my estimated ten-year risk, and which of my numbers is contributing most to it?
• Are there factors about my history, family or health conditions that push my risk higher or lower than the calculator suggests?
• Would a coronary calcium scan or another test change what you recommend for me, or would it only add information without changing the plan?
• Which of my risk factors do you want to address first, and what target are you aiming for?
• If you are suggesting a medicine, what does it do mechanically, how will we know it is working, and what side effects should I report?
• If I chose lifestyle changes alone for now, how long would you want to wait before rechecking, and what result would prompt a change?
• Do I have symptoms that need investigating, or is this purely about prevention?
• If a procedure is being discussed, what will it change about my symptoms, what will it not change about my risk, and what are the alternatives?
• Am I eligible for cardiac rehabilitation, and how do I access it?
• Which warning signs should make me call you, and which should make me call emergency services?
• How often should my cholesterol, blood pressure and glucose be rechecked, and who will coordinate that?
• Are there interactions between my heart medicines and anything else I take, including supplements?

Writing the answers down during the appointment, or bringing someone who can, makes the plan easier to follow at home. If a recommendation is unclear, asking the clinician to explain the reasoning behind it, rather than only the instruction, usually produces a plan that is easier to stick with.

When to call your doctor

Most of atherosclerosis care happens calmly, over years. A small number of moments do not, and knowing which is which is part of living well with the condition.

Call emergency services immediately, rather than driving yourself or waiting to see if it passes, for chest pressure, tightness, squeezing or heaviness lasting more than a few minutes or recurring; discomfort that spreads to the arm, jaw, neck, back or upper stomach; chest discomfort accompanied by breathlessness, sweating, nausea or lightheadedness; sudden weakness or numbness of the face, arm or leg, especially on one side; sudden trouble speaking or understanding speech, sudden loss of vision, or sudden severe imbalance; or fainting. Women and people with diabetes are somewhat more likely to experience heart attack as breathlessness, fatigue or nausea without classic chest pain, and those symptoms deserve the same urgency when they are sudden and unexplained. A leg that suddenly becomes painful, pale and cold is also an emergency.

Contact your doctor promptly, within a day or two, for chest discomfort or breathlessness that appears with exertion and settles with rest, which is a new pattern; angina that is coming on with less effort than before or lasting longer; unexplained swelling of the ankles or sudden weight gain; new muscle pain, dark urine or unusual weakness after starting a cholesterol medicine; unusual bruising, black stools or nosebleeds that are hard to stop while taking antiplatelet medicines; dizziness on standing after a blood-pressure medicine change; or redness, swelling, discharge or increasing pain at a procedure site.

Raise at the next routine appointment anything that puzzles you: a reading at home that seems out of step, a supplement you are considering, a side effect you have been tolerating, or a change in circumstances that makes the current plan harder to follow. Silence about these things is the most common way a good plan quietly stops working.

Frequently asked questions

What are 5 symptoms of atherosclerosis?

Atherosclerosis itself usually causes no symptoms until an artery is significantly narrowed or blocked, which is why risk assessment matters more than waiting for warning signs. When symptoms do occur they depend on the artery involved: chest pressure on exertion from the heart’s arteries, leg pain when walking from leg arteries, and sudden weakness, speech difficulty or vision loss from arteries supplying the brain. Any of these should be assessed by a clinician rather than self-diagnosed.

Can you live a long life with atherosclerosis?

Many people do, and the condition is common enough that most adults over middle age have some degree of it. What shapes the long-term picture is not the presence of plaque but whether the drivers of progression, cholesterol, blood pressure, smoking and blood sugar, are brought under control and kept there. Guideline-based treatment reduces the likelihood of heart attack and stroke substantially in trials; no clinician can promise an individual outcome, but the trajectory is highly modifiable.

Can you clear up atherosclerosis?

No treatment clears plaque from arteries entirely. Intensive cholesterol lowering can make soft plaque smaller and more stable, and imaging trials have shown modest regression in some people, but calcified deposits remain. Claims that supplements, special diets or chelation infusions dissolve plaque are not supported by controlled evidence, and chelation carries risks. The realistic and evidence-based aim is stabilizing plaque and preventing events rather than eliminating the disease.

How long does it take to reverse atherosclerosis?

There is no single honest figure. Imaging studies that documented modest plaque shrinkage with intensive LDL lowering ran for roughly one to two years and showed gradual change rather than a turning point. The outcome that matters, fewer heart attacks and strokes, accumulates over years of sustained treatment. Clinicians therefore track blood pressure, cholesterol and symptoms over time rather than repeating scans to measure reversal.

What are the main atherosclerosis treatment options?

They fall into three layers. Lifestyle changes, including not smoking, regular activity and a heart-protective eating pattern, apply to everyone. Medicines, chiefly cholesterol-lowering, blood-pressure and antiplatelet classes, are added according to estimated risk and established disease. Procedures such as angioplasty with a stent or bypass surgery are used for heart attacks and for symptoms that medicines cannot control. The layers are cumulative rather than alternatives, and the mix is decided with the treating team.

Is a stent better than medicines for coronary artery disease?

It depends on the situation. During a heart attack, opening the artery promptly with a stent limits heart muscle damage and is the standard of care. In stable disease, large randomized trials found that adding a stent to good medical treatment improved angina for many people but did not reduce future heart attacks or deaths compared with medicines alone. Guidelines therefore use stents in stable disease mainly for symptoms that persist despite medicines.

What does a coronary calcium score tell me?

A coronary artery calcium scan is a quick CT that counts calcified plaque in the heart’s arteries and expresses it as a score. It is most useful when a risk calculator gives a borderline result: a score of zero is reassuring and may support waiting, while a high score often tips the decision toward medicine. It does not measure soft plaque, and it is generally not repeated to track treatment because calcium tends to persist.

Do I need treatment if my cholesterol is normal?

Possibly. Cholesterol is one input into risk, not the whole calculation. Someone with an average LDL but raised blood pressure, diabetes, a smoking habit or a strong family history can carry a higher overall risk than a non-smoker with higher cholesterol and nothing else. Lifestyle measures apply regardless, and whether medicines are advised depends on the combined estimate and any established disease, which is a judgment for your clinician.

What does coronary artery disease progression depend on?

Three measurable forces drive it: the amount of LDL cholesterol entering the artery wall, the mechanical and chemical injury to the lining from high blood pressure, smoking and high blood sugar, and the degree of inflammation within the plaque. Genetics set the starting point, and inherited conditions such as familial hypercholesterolemia accelerate it. Because each driver can be measured and modified, progression is not fixed, and the same plaque can stabilize or grow depending on how those forces are managed.

Can you reverse atherosclerosis with diet alone?

Diet can lower cholesterol, blood pressure and inflammation meaningfully, and a Mediterranean-style pattern has reduced cardiovascular events in trials. It has not been shown to remove established plaque. For people at low risk, diet and activity may be all that is advised. For those at higher risk or with existing disease, diet is the foundation to which medicines are usually added, since lifestyle alone often cannot reach the targets clinicians set.

References

• Atherosclerosis, MedlinePlus (NIH National Library of Medicine)
• Atherosclerosis (arteriosclerosis), NHS
• Coronary artery bypass graft (CABG), NHS

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.